Amgen’s New Prostate Cancer Study: A Potential Game-Changer?

5 days ago 5

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 clinical study titled ‘A Phase 3, Open-label, ...

1. Homepage
2. Prostate Cancer
3. Amgen’s New Prostate Cancer Study: A Potential Game-Changer?